cryoport delivers an innovative and complete outsourced frozen shipping solution for biological materials. this breakthrough combination replaces outdated dry ice shipping, virtually eliminates the risk of cell degradation and revolutionizes deep frozen logistics. we combine the technology of liquid nitrogen dry vapor shippers with the most advanced logistics management platform in the industry. when added with our logistics expertise, we provide a complete outsourced solution that advances deep-frozen shipping for the life science community. whether your business is bio-pharmaceuticals, clinical trials, research or reproductive medicine, you want to focus on your core mission. cryoport will help you transport life.
Company profile
Ticker
CYRX
Exchange
Website
CEO
Jerrell W. Shelton
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
CRYOPORT SYSTEMS INC
SEC CIK
Corporate docs
Subsidiaries
Cryogene, Inc. • Cryoport Systems, LLC • MVE Biological Solutions US, LLC • Cryoport Netherlands BV • Cryoport France, SAS • Cryoport UK Limited • Cryoport Belgium SA • Cryoport Germany, GmbH • Cell&Co, SAS • Bluebird Express, LLC ...
IRS number
880313393
CYRX stock data
Latest filings (excl ownership)
10-K
2023 FY
Annual report
13 Mar 24
8-K
Cryoport Reports Fourth Quarter and Full Year 2023 Financial Results
12 Mar 24
8-K
Departure of Directors or Certain Officers
15 Feb 24
424B3
Prospectus supplement
21 Dec 23
EFFECT
Notice of effectiveness
20 Dec 23
POS AM
Prospectus update (post-effective amendment)
15 Dec 23
POSASR
Automatic shelf registration (post-effective amendment)
15 Dec 23
8-K
Amendments to Articles of Incorporation or Bylaws
15 Nov 23
10-Q
2023 Q3
Quarterly report
9 Nov 23
8-K
Cryoport Reports Third Quarter 2023 Financial Results
8 Nov 23
Transcripts
CYRX
Earnings call transcript
2023 Q4
12 Mar 24
CYRX
Earnings call transcript
2023 Q3
8 Nov 23
CYRX
Earnings call transcript
2023 Q2
9 Aug 23
CYRX
Earnings call transcript
2023 Q1
4 May 23
CYRX
Earnings call transcript
2022 Q4
23 Feb 23
CYRX
Earnings call transcript
2022 Q3
3 Nov 22
CYRX
Earnings call transcript
2022 Q2
6 Aug 22
CYRX
Earnings call transcript
2022 Q1
8 May 22
CYRX
Earnings call transcript
2021 Q4
25 Feb 22
CYRX
Earnings call transcript
2021 Q3
5 Nov 21
Latest ownership filings
4
ROBERT STEFANOVICH
26 Mar 24
4
JERRELL SHELTON
26 Mar 24
4
Mark W Sawicki
26 Mar 24
4
EDWARD J ZECCHINI
19 Mar 24
4
ROBERT STEFANOVICH
19 Mar 24
4
Mark W Sawicki
19 Mar 24
4
Ramkumar Mandalam
19 Mar 24
4
LINDA BADDOUR
19 Mar 24
4
JERRELL SHELTON
19 Mar 24
144
Notice of proposed sale of securities
15 Mar 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 59.47 mm | 59.47 mm | 59.47 mm | 59.47 mm | 59.47 mm | 59.47 mm |
Cash burn (monthly) | 2.61 mm | (no burn) | 5.64 mm | 4.69 mm | 653.00 k | (no burn) |
Cash used (since last report) | 15.65 mm | n/a | 33.74 mm | 28.10 mm | 3.91 mm | n/a |
Cash remaining | 43.83 mm | n/a | 25.73 mm | 31.38 mm | 55.56 mm | n/a |
Runway (months of cash) | 16.8 | n/a | 4.6 | 6.7 | 85.1 | n/a |
Institutional ownership, Q3 2023
13F holders | Current |
---|---|
Total holders | 161 |
Opened positions | 15 |
Closed positions | 31 |
Increased positions | 48 |
Reduced positions | 65 |
13F shares | Current |
---|---|
Total value | 594.04 bn |
Total shares | 54.09 mm |
Total puts | 495.20 k |
Total calls | 429.80 k |
Total put/call ratio | 1.2 |
Largest owners | Shares | Value |
---|---|---|
Brown Capital Management | 7.91 mm | $108.51 bn |
Blackstone Holdings III | 5.87 mm | $462.75 mm |
Vanguard | 3.56 mm | $48.80 bn |
BLK Blackrock | 3.17 mm | $43.46 bn |
Alger Associates | 2.72 mm | $0.00 |
Cadian Capital Management | 2.66 mm | $36.42 bn |
Impax Asset Management | 2.60 mm | $35.38 bn |
Fred Alger Management | 2.39 mm | $32.79 bn |
IVZ Invesco | 2.06 mm | $28.28 bn |
MS Morgan Stanley | 1.53 mm | $20.91 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
25 Mar 24 | Mark W Sawicki | Common Stock | Sell | Dispose S | No | No | 17.5423 | 1,367 | 23.98 k | 77,444 |
25 Mar 24 | Shelton Jerrell | Common Stock | Sell | Dispose S | No | No | 17.5423 | 2,631 | 46.15 k | 692,182 |
25 Mar 24 | Stefanovich Robert | Common Stock | Sell | Dispose S | No | No | 17.5423 | 1,079 | 18.93 k | 128,333 |
15 Mar 24 | Zecchini Edward J | Common Stock | Grant | Acquire A | No | No | 0 | 10,455 | 0.00 | 63,494 |
15 Mar 24 | Zecchini Edward J | Stock Option Common Stock | Grant | Acquire A | No | No | 16.7 | 20,910 | 349.20 k | 20,910 |
15 Mar 24 | Linda Baddour | Common Stock | Option exercise | Acquire M | No | No | 0 | 1,111 | 0.00 | 21,690 |
15 Mar 24 | Linda Baddour | Restricted Stock Rights Common Stock | Option exercise | Dispose M | No | No | 0 | 1,111 | 0.00 | 0 |
News
Analyst Ratings For CryoPort
15 Mar 24
UBS Maintains Neutral on CryoPort, Raises Price Target to $17
15 Mar 24
Build-A-Bear Workshop Reports Upbeat Earnings, Joins VAALCO Energy, Dick's Sporting Goods And Other Big Stocks Moving Higher On Thursday
14 Mar 24
Stephens & Co. Reiterates Equal-Weight on CryoPort, Maintains $17 Price Target
13 Mar 24
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
13 Mar 24